Ron Bentsur - 23 Mar 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
23 Mar 2023
Net transactions value
+$2,790
Form type
4
Filing time
27 Mar 2023, 08:21:56 UTC
Previous filing
23 Mar 2023
Next filing
18 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $2,790 +230 +0.01% $12.13 3,228,329 23 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 96,759 shares of restricted stock and 330,000 restricted stock units.